Intellectual Property Apellate Board stays cancellation of Novartis patent for Anti-Cancer Drug Ceritinib Farhat Nasim5 Oct 2020 3:33 PM ISTNew Delhi: The Intellectual Property Apellate Board (IPAB) has recently stayed the cancellation of the Swiss drugmaker Novartis' patent over the...
Natco Pharma to launch new products in non-oncology segment Ruchika Sharma22 Sept 2020 11:00 AM ISTNew Delhi: Natco Pharma plans to diversify its product portfolio in the domestic market as it aims to make up for a drop in business of some of its...
Natco Pharma, Celgene ink pact for cancer treatment drug Lenalidomide Ruchika Sharma11 July 2020 12:47 PM ISTLenalidomide is used to treat various types of cancers.
Natco Pharma net profit falls 23 pc at Rs 93.2 crore in Q4 Ruchika Sharma19 Jun 2020 10:00 AM ISTNew Delhi: Drug firm Natco Pharma on Wednesday reported a 22.59 per cent decline in its consolidated net profit at Rs 93.2 crore for the quarter ended...
COVID 19: Natco Pharma supports Columbia University trials for CQ tablets to prevent infections Ruchika Sharma25 May 2020 1:30 PM ISTThe company said researchers at Columbia University are conducting this critical study to assess CQ as prophylaxis against COVID-19 in healthcare...
Natco Pharma receives USFDA EIR for Vizag facility Ruchika Sharma21 May 2020 12:00 PM ISTAndhra Pradesh: Natco Pharma Limited has announced the successful closure of inspection and receipt of an Establishment Inspection Report (EIR) from...
Natco Pharma gets USFDA nod for Vizag Formulation Facility Ruchika Sharma29 April 2020 12:58 PM ISTHyderabad: Natco Pharma Limited has announced the final approval of its 1st supplemental abbreviated new drug application (sANDA) product from the...
Natco Pharma gets USFDA EIR for Telangana facility Ruchika Sharma27 April 2020 10:49 AM ISTHyderabad: Natco Pharma Limited has announced the successful closure of inspection with an Establishment Inspection Report (EIR) from the U.S. Food...
Natco Pharma Q3 net profit rises over two-fold to Rs 37.15 cr savita12 Feb 2016 8:11 AM ISTNew Delhi: Drug firm Natco Pharma reported over two-fold jump in consolidated net profit at Rs 37.15 crore for the third quarter ended December...
Natco settles patent litigation with Celgene on cancer drug savita24 Dec 2015 11:49 AM ISTNew Delhi: Natco Pharma and its US partner Allergan have settled a pending litigation with biopharmaceutical firm Celgene regarding generic...
Natco Pharma gets DCGI nod to sell hepatitis C treatment drug savita15 Dec 2015 10:45 AM ISTNew Delhi: Drug major Natco Pharma has got approval from the Drugs Controller General of India (DCGI) to sell generic version of Daclatasvir, which is...
Natco settles patent suit with Gilead, others over Tamiflu savita15 Dec 2015 10:43 AM ISTNew Delhi: Natco Pharma and its partner Alvogen said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu, in a...
